Hijacking Immune-Cell Specific E3 Ligases for Targeted Protein Degradation 2022 ASPIRE Award Georg Winter, PhD, CeMM- Research Center for Molecular Medicine (Austria); Steve Gygi, PhD, Harvard Medical School Read More
Harnessing Induced Proximity to Expand Cancer Therapeutic Modalities 2022 ASPIRE Award Mikko Taipale, PhD, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto; Daniel Durocher, PhD, Frank Sicheri, PhD, Mount Sinai Hospital (Canada) Read More
Defining Tumor Infiltrating B Cells and Their Role in the Modulation of TIL Immunotherapy 2022 ASPIRE Award Shari Pilon-Thomas, PhD; Daniel Abate-Daga, PhD, H. Lee Moffitt Cancer Center and Research Institute; Yong-Chen Lu, PhD, University of Arkansas for Medical Sciences Read More
Reprograming Regulatory T Cells for Cancer Immunotherapy 2022 ASPIRE Award Xiongbin Lu, PhD, Indiana University School of Medicine and Indiana University Melvin and Bren Simon Comprehensive Cancer Center, USA Read More
Targeting SCLC Plasticity with Constellation Pharmacology 2022 ASPIRE Award Trudy Oliver, PhD; Baldomero Olivera, PhD, Huntsman Cancer Institute at the University of Utah Read More
Targeting Androgen Receptor Condensates in Castration Resistant Prostate Cancer 2022 ASPIRE Award; 2024 ASPIRE II Award Denes Hnisz, PhD, Max Planck Institute for Molecular Genetics (Germany) and Xavier Salvatella, PhD, Institute for Research in Biomedicine (IRB Barcelona) Read More
